Afficher la fiche abrégée

dc.date.accessioned2014-03-22T18:18:32Z
dc.date.available2014-03-22T18:18:32Z
dc.date.issued2012
dc.identifier.urihttp://www.who.int/iris/handle/10665/109384
dc.language.isoenEN
dc.relation.ispartofseriesWHO Drug Information 2012; 26(‎1)‎ : 35
dc.subject.otherPharmaceuticals and Biologicals
dc.titleEcallantide: marketing authorization application withdrawalEN
dc.typeJournal / periodical articlesEN


Fichier(‎s)‎ constituant ce document

Thumbnail

Ce document figure dans la(‎les)‎ collection(‎s)‎ suivante(‎s)‎

Afficher la fiche abrégée